A Multistage Pathway for Human Prion Protein Aggregation in Vitro: From Multimeric Seeds to β-Oligomers and Nonfibrillar Structures

Kang R. Cho, Yu Huang*, Shuiliang Yu§, Shaoman Yin§, Marco Plomp, S. Roger Qiu, Rajamani Lakshminarayanan, Janet Moradian-Oldak, Man-Sun Sy§, and James J. De Yoreo*
Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, United States
Department of Materials Science and Engineering, University of California, Los Angeles, Los Angeles, California 90095, United States
§ Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, United States
Center for Craniofacial Molecular Biology, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, California 90033, United States
Molecular Foundry, Lawrence Berkeley National Laboratory, Berkeley, California 94720, United States
J. Am. Chem. Soc., 2011, 133 (22), pp 8586–8593
DOI: 10.1021/ja1117446
Publication Date (Web): May 2, 2011
Copyright © 2011 American Chemical Society

# Author Present Address

Singapore Eye Research Institute, 7 Hospital Drive, Block C, 02-02, Singapore 169611.

Abstract

Abstract Image

Aberrant protein aggregation causes numerous neurological diseases including Creutzfeldt–Jakob disease (CJD), but the aggregation mechanisms remain poorly understood. Here, we report AFM results on the formation pathways of β-oligomers and nonfibrillar aggregates from wild-type full-length recombinant human prion protein (WT) and an insertion mutant (10OR) with five additional octapeptide repeats linked to familial CJD. Upon partial denaturing, seeds consisting of 3–4 monomers quickly appeared. Oligomers of 11–22 monomers then formed through direct interaction of seeds, rather than by subsequent monomer attachment. All larger aggregates formed through association of these β-oligomers. Although both WT and 10OR exhibited identical aggregation mechanisms, the latter oligomerized faster due to lower solubility and, hence, thermodynamic stability. This novel aggregation pathway has implications for prion diseases as well as others caused by protein aggregation.

Citing Articles

View all 5 citing articles

Citation data is made available by participants in CrossRef's Cited-by Linking service. For a more comprehensive list of citations to this article, users are encouraged to perform a search in SciFinder.

This article has been cited by 1 ACS Journal articles (1 most recent appear below).

Tools

SciFinder Links

SciFinder subscribers:  Click to sign in | Not a SciFinder subscriber? Learn more at www.cas.org

Explore by:


History

  • Published In Issue June 08, 2011
  • Article ASAPMay 17, 2011
  • Just Accepted ManuscriptMay 02, 2011
  • Received: December 30, 2010

Recommend & Share

  • Share on ACS NetworkACS Network
  • Add to FacebookFacebook
  • Tweet ThisTweet This
  • Add to CiteULikeCiteULike
  • Add to NewsvineNewsvine
  • Digg ThisDigg This
  • Add to DeliciousDelicious

Related Content

Other ACS content by these authors: